TXMD - CONSENSUS CO - TherapeuticsMD, Inc.

TherapeuticsMD, Inc. (TXMD) relies on a protected patent pool of bioidentical hormones and long-term agreements with B2B insurers, ensuring a stable market position. This daily price chart reflects the current value of 5.01. The business focuses on developing soft therapeutic agents for women, with the primary priority being the treatment of menopause symptoms, which attracts a highly loyal customer base within a massive market segment.

This metric aggregates disparate investment bank price targets into a continuous array, allowing investors to quickly identify pricing anomalies and avoid overvaluations. By analyzing the consensus forecast indicator for the stock, one can assess the fundamental value of TherapeuticsMD, Inc. (TXMD), which is supported by high barriers to entry in the women's health sector due to costly manufacturing certifications and patent protection for drugs.